Geovax Labs currently holds 198.06
K in liabilities with Debt to Equity (D/E) ratio of 0.02, which may suggest the company is not taking enough advantage from borrowing. Geovax Labs is UNDERVALUED at 6.51 per share with modest projections ahead.
We determine the current worth of GeoVax Labs using both absolute as well as relative valuation methodologies to arrive at its intrinsic value. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of GeoVax Labs based exclusively on its
fundamental and basic
technical indicators. By analyzing GeoVax Labs's
financials, quarterly and monthly indicators, and related drivers such as
dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of GeoVax Labs's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of GeoVax Labs. We calculate exposure to GeoVax Labs's
market risk, different
technical and
fundamental indicators, relevant financial multiples and ratios, and then
comparing them to GeoVax Labs's related companies.
GeoVax Labs Investment Alerts
GeoVax investment alerts and warnings help investors to get more proficient at understanding not only critical technical and fundamental signals but also the significant portfolio-centered indicators. These indicators include beta, alpha, and other risk-related measures that will help you in monitoring GeoVax Labs performance across your portfolios.Please check all
investment alerts for GeoVax
GeoVax Labs Valuation Ratios as Compared to Competition
Our valuation model uses many indicators to compare GeoVax value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across GeoVax Labs competition to find
correlations between indicators driving the intrinsic value of GeoVax.
GeoVax Labs Gross Profit
GeoVax Labs Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing GeoVax Labs previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show GeoVax Labs Gross Profit growth over the last 10 years. Please check GeoVax Labs'
gross profit and other
fundamental indicators for more details.
Another angle On GeoVax Labs
The entity reported the previous year's revenue of 1.82
M. Net Loss for the year was (2.96
M) with loss before overhead, payroll, taxes, and interest of (620.8
K).
Margins Breakdown
Geovax profit margins show the degree to which it makes money. Margin indicators are used not only by investors but also by creditors or Geovax Labs itself as indicators of financial health and management effectiveness. Please look more closely at the different varieties of Geovax Labs profit margins.
| EBITDA Margin | (1.65) |
| Gross Margin | 0.89 |
| Profit Margin | (1.75) |
Geovax Labs Average Assets is fairly stable at the moment. Moreover, Geovax Labs Earnings Before Interest Taxes and Depreciation Amortization USD is fairly stable at the moment.
Geovax Labs implied volatility may change after the rise
Geovax Labs current jensen alpha rises over 0.82. Geovax Labs is displaying above-average volatility over the selected time horizon. Investors should scrutinize Geovax Labs independently to ensure intended market timing strategies are aligned with expectations about Geovax Labs volatility. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Geovax Labs' stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Geovax Labs' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.
Our Final Take On Geovax Labs
While many other companies within the biotechnology industry are still a little expensive, even after the recent corrections, Geovax Labs may offer a potential longer-term growth to investors. All things considered, as of the 13th of April 2021, our primary 30 days buy-or-sell advice on the company is
Hold. We believe Geovax Labs is
undervalued with
very small chance of distress for the next two years.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
Raphi Shpitalnik is a Junior Member of Macroaxis Editorial Board. Raphael is a young entrepreneur who joined Macroaxis on a part-time basis at the beginning of the pandemic and eventually acquired a real taste for investing and fintech. He likes to analyze different equity instruments across a wide range of industries, focusing primarily on consumer products, sports, fintech, cannabis, and AI.
View Profile This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Raphi Shpitalnik do not own shares of GeoVax Labs. Please refer to our
Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to
editors@macroaxis.com
